Immunome Inc (IMNM)
14.15
+0.33
(+2.39%)
USD |
NASDAQ |
Apr 30, 12:34
Immunome Total Liabilities (Quarterly): 28.66M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 28.66M |
| September 30, 2023 | 87.08M |
| June 30, 2023 | 32.10M |
| March 31, 2023 | 34.25M |
| December 31, 2022 | 7.393M |
| September 30, 2022 | 7.462M |
| June 30, 2022 | 8.742M |
| March 31, 2022 | 9.854M |
| Date | Value |
|---|---|
| December 31, 2021 | 9.74M |
| September 30, 2021 | 7.765M |
| June 30, 2021 | 3.524M |
| March 31, 2021 | 4.71M |
| December 31, 2020 | 3.18M |
| September 30, 2020 | 61.07M |
| June 30, 2020 | 3.13M |
| December 31, 2019 | 40.69M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.13M
Minimum
Jun 2020
87.08M
Maximum
Sep 2023
21.83M
Average
9.241M
Median
Total Liabilities (Quarterly) Benchmarks
| Ayala Pharmaceuticals Inc | 41.00M |
| Tenax Therapeutics Inc | 3.586M |
| GE HealthCare Technologies Inc | 25.14B |
| Exelixis Inc | 678.44M |
| Puma Biotechnology Inc | 177.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 148.54M |
| Shareholders Equity (Quarterly) | 119.88M |
| Current Ratio | 6.629 |